drugset
drugset / Trial / NCT01878461

Evaluate the Efficacy and Safety of M518101 in Subjects With Plaque Psoriasis

NCT01878461 ↗

Phase 3 Completed 542 enrolled Maruho North America Inc.
RandomizedParallel-groupDouble-blindTreatment

Summary

This study is to evaluate the efficacy and safety of M518101 in subjects with plaque psoriasis

Timeline

Start
2013-06
Primary completion
2015-05
Completion
2015-05

Drugs

EvaluationDrugModalityDoseRoute
Subject pefcalcitol Small molecule — —

Indications

psoriasis